The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement Note from PICI’s President and CEO Jeff Bluestone: Introducing Our New Brand Clinical Trial The PORTER Trial Our Impact Informatics Accelerates the PRINCE Pancreatic Cancer Clinical Trial Our Impact PICI BioTrust Decodes Triple Negative Breast Cancer in TRIBUTE Collaboration Our Impact Improve Life After Cancer: Addressing Autoimmunity Partner Highlight Nonprofits Join Forces for a Cure: Cancer Research Institute Research Update Where Cancer-killing T-cells Come From